A carregar...
Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy
PURPOSE: Gonadotropin-releasing hormone agonist (GnRHa) is a safe and effective therapy used to treat central precocious puberty (CPP). Although most studies have reported no significant difference in body mass index (BMI) in girls during and after GnRHa therapy, few studies have investigated change...
Na minha lista:
| Publicado no: | Ann Pediatr Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society of Pediatric Endocrinology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7538302/ https://ncbi.nlm.nih.gov/pubmed/33017886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6065/apem.1938176.088 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|